1 Min Read
June 19 (Reuters) - Merrimack Pharmaceuticals Inc
* Merrimack announces completion of enrollment in phase 2 carrie study of mm-141; data expected in first half of 2018 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.